Richard Bruno
Foot & Ankle Surgery · Suffolk, VANPI 1013440569
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $105,246 of the $168,708 with a category attached, or 62.4%. Kerecis Limited accounts for 87.7% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $51,394, more than ten times the $19 reported in 2019. Among foot & ankle surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $549.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$148K
- Stryker$10K
- Fortis Surgical, LLC$4K
- Arthrex$1K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$850
- Orthofix Medical, Inc.$672
- plus $4K from 22 others
What the payments were for
- Consulting fees$16,70010%
- Speaking & faculty fees$105,24662%
- Travel & lodging$25,14015%
- Food & beverage$14,6189%
- Education$7,0044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 87 | $147,887 |
| Stryker(2 entities) | 138 | $9,555 |
| Fortis Surgical, LLC | 23 | $4,360 |
| Arthrex | 3 | $1,435 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $850 |
| Orthofix Medical, Inc. | 10 | $672 |
| Smith+Nephew | 4 | $371 |
| Paragon 28, Inc. | 4 | $362 |
| Integra Lifesciences Corporation | 4 | $331 |
| Lifenet Health | 5 | $317 |
| Linvatec Corporation | 3 | $293 |
| In2bones USA, LLC | 4 | $283 |
| Anika Therapeutics, Inc. | 2 | $273 |
| Ossio Inc | 1 | $155 |
| Sanara Medtech Inc. | 1 | $149 |
| Access Pro Medical, LLC | 1 | $145 |
| Trice Medical, Inc. | 1 | $130 |
| Bioventus LLC | 2 | $127 |
| Amgen | 1 | $125 |
| W. L. Gore & Associates, Inc. | 1 | $123 |
| Paratek Pharmaceuticals, Inc. | 1 | $122 |
| Medtronic | 1 | $121 |
| Innovation Technologies Inc | 1 | $110 |
| Forma Medical | 1 | $105 |
| Heron Therapeutics, Inc. | 1 | $98 |
| Johnson & Johnson | 2 | $75 |
| AbbVie | 3 | $74 |
| Flower Orthopedics Coporation | 1 | $58 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$265,134
- Kerecis Omega3 SurgiClose$191,729
- Kerecis SurgiClose$178,544
- Kerecis Omega3 GraftGuide$57,432
- Kerecis GraftGuide$44,636
- PROstep$1,415
- PROPHECY$1,043
- VARIAX$917
- JUBLIA$850
- INFINITY ADAPTIS$835
- TL-HEX$498
- TrueLok Ring Fixation System$498
- INTEGRA$462
- CITREFIX$443
- HOFFMANN$438
- Viaflow$433
- EASY CLIP$374
- T2$315
- ASNIS$284
- TACTOSET$273
How this compares
$168,708 in reported general payments places this provider in the 95th percentile of 260 foot & ankle surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 11 | $15,337 |
| Gabapentin | 95 | $1,347 |
| Ammonium Lactate | 39 | $929 |
| Ciclopirox | 31 | $818 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 53 | $721 |
| Baclofen | 41 | $665 |
| Doxycycline Hyclate | 58 | $516 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $277 |
| Prednisone | 21 | $218 |
| Pregabalin | 17 | $209 |
| Clindamycin Hcl | 17 | $190 |
| Meloxicam | 61 | $163 |
| Ciprofloxacin Hcl | 13 | $153 |
| Cyclobenzaprine Hcl | 17 | $63 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $850 | $15,33711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 260 foot & ankle surgery providers in Virginia.
Other foot & ankle surgery in Suffolk
- Davin CarrollSuffolk$14K
- Namrata DaruSuffolk$11K
- Gerard CostellaSuffolk$10K
- Mark JonesNorth Chesterfield$2.4M
- Oliver SchipperArlington$1.2M
- Steven NeufeldFalls Church$857K
- Charles ZelenRoanoke$363K
- Ryan VazalesGlen Allen$337K
- Jugal DhariaFairfax$309K
- William SimonVirginia Beach$292K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.